Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,320 recruiting studies in this area right now.
By phase
- Not applicable9,604
- Phase 24,428
- Phase 12,683
- Phase 1/Phase 21,650
- Phase 31,400
- Phase 2/Phase 3287
- Phase 4268
Top conditions
- Breast Cancer1,207
- Prostate Cancer646
- Cancer638
- Colorectal Cancer479
- Lung Cancer421
- Ovarian Cancer342
- Multiple Myeloma329
- Pancreatic Cancer288
- Gastric Cancer285
- Acute Myeloid Leukemia283
- Hepatocellular Carcinoma257
- Solid Tumor246
- Advanced Solid Tumor232
- Head and Neck Cancer228
- Cervical Cancer226
- Endometrial Cancer214
- Advanced Solid Tumors207
- Esophageal Cancer192
Leading sponsors
- M.D. Anderson Cancer Center455
- Fudan University305
- National Cancer Institute (NCI)294
- Memorial Sloan Kettering Cancer Center290
- Sun Yat-sen University275
- Mayo Clinic237
- City of Hope Medical Center146
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences145
- AstraZeneca132
- Ruijin Hospital128
Where studies are running
- California1,397
- Texas632
- Arizona508
- Florida436
- Alabama430
- New York405
- Massachusetts340
- Maryland331
- New Jersey275
- Pennsylvania235
Recruiting studies20,320 total
- NCT06815666RecruitingPhase 2
Lung fluid study for sarcoma patients having surgery
This study looks at fluid from the lungs of people with soft tissue sarcoma who are having surgery to remove a lung tumor. Researchers hope these samples can help understand the disease better.
Toronto, OntarioAges 18 years+ - NCT06821997RecruitingPhase 2
Chemotherapy before surgery for borderline resectable pancreatic cancer
This trial tests a combination of chemotherapy drugs (NALIRIFOX) given before surgery to shrink the tumor in people with a specific type of pancreatic cancer. The goal is to make surgery more effective and improve outcomes.
Buffalo, New YorkAges 18 years+ - NCT06822543RecruitingPhase 2
A new treatment for lung cancer that has spread to the brain
This trial tests a combination of three drugs (datopotamab deruxtecan, carboplatin, and pembrolizumab) for people with a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to the brain and has not been treated before. The goal is to see if this combination can shrink tumors in the brain and elsewhere.
Fortaleza, CearáAges 18 years+ - NCT06818916Recruiting
A study of hetrombopag to help platelets recover after stem cell transplant for neuroblastoma
This trial tests if a drug called hetrombopag can help children with neuroblastoma recover their platelet counts more quickly after their own stem cells are transplanted. It aims to reduce the time needed for platelet engraftment and lower the risk of bleeding.
BeijingAges Up to 18 years - NCT06824974Recruiting
Time-restricted eating for liver disease or cancer
This study tests whether combining time-restricted eating with healthy eating helps people with metabolic liver disease, cirrhosis, or early-stage liver cancer. If you are overweight and currently fast less than 12 hours at night, this diet approach might improve your health.
La Jolla, CaliforniaAges 18 years+ - NCT06815497RecruitingPhase 2
Telmisartan plus chemo for platinum-resistant ovarian cancer
This trial tests adding telmisartan (a blood pressure medicine) to standard chemotherapy for people with ovarian cancer that no longer responds to platinum-based drugs. The goal is to see if the combination can help control the cancer better.
Lebanon, New HampshireAges 18 years+ - NCT06817694Recruiting
CBT for fear of cancer returning in BRCA1/2 women
This trial tests if cognitive behavioral therapy can reduce fear of cancer recurrence in women with BRCA1/2 mutations who have finished treatment for breast or ovarian cancer. It aims to help you cope with worries about cancer coming back.
Québec, QuebecAges 18 years+ - NCT06824688Recruiting
Comparing robotic surgery types for rectal cancer
This trial compares two robotic surgery methods for rectal cancer: using one small incision (single-port) versus several small incisions (multi-port). The goal is to see which approach offers better outcomes while preserving the sphincter (the muscle that controls bowel movements).
ChongqingAges 18 years+ - NCT06817668Recruiting
Testing a new radiation approach for prostate cancer
This study is testing a new way of giving radiation for prostate cancer, called ePUHRT, combined with a standard brachytherapy boost (a small radioactive implant placed inside the prostate). It aims to see if this approach is well-tolerated and safe for people with higher-risk prostate cancer.
Indianapolis, IndianaAges 18 years+ - NCT06821243Recruiting
Finding markers in HPV-related throat cancer to guide treatment
This study looks for certain markers in people with HPV-related throat cancer that could help doctors choose the best treatment. If you are planning to have surgery for your throat cancer, you may be able to join.
Rome, RomeAges 18 years+ - NCT06816134RecruitingPhase 2
TmBU chemo before stem cell transplant for high-risk leukemia
This clinical trial tests a new combination of chemotherapy drugs (called TmBU) before a stem cell transplant for people with high-risk or relapsed acute leukemia. The goal is to see if this conditioning regimen works better and is safe for patients who need a transplant.
Suzhou, JiangsuAges 15–65 - NCT06820164RecruitingPhase 1/Phase 2
Salt-water shots for lipomas under the skin
This study tests injecting cooled or warmed salt water (saline) into lipomas—harmless fatty lumps under the skin—to see if it can shrink or remove them without surgery. It's for people with a single lipoma or many, as long as they're not on the face, too big, or growing fast.
Morgantown, West VirginiaAges 18 years+ - NCT06824818Recruiting
Can older men stop prostate cancer treatment early?
This study looks at whether men aged 70 or older who have been on hormone therapy for over 3 years can safely stop treatment. It aims to find out if stopping early helps maintain quality of life without letting the cancer come back.
Chicago, IllinoisAges 70 years+ - NCT06825091RecruitingPhase 3
Comparing new SBRT to standard radiation for prostate cancer
This trial compares a newer, more precise type of radiation (adaptive SBRT) with standard image-guided radiation for prostate cancer. It aims to see if the newer approach is better at targeting the tumor while reducing side effects.
Toronto, OntarioAges 18 years+ - NCT06818994RecruitingPhase 1
Psilocybin therapy for low mood in advanced cancer
This trial tests if a medicine called psilocybin, given with talk therapy, can safely help people with advanced cancer who feel very demoralized. Demoralization is a deep sense of hopelessness or loss of meaning. The goal is to see if this treatment can improve your emotional well-being.
Kingston, OntarioAges 18–70 - NCT06825078Recruiting
Lung MRI with synthetic CT for monitoring lung nodules
This study tests whether using an MRI combined with a special type of CT scan can effectively monitor lung nodules over time. It may help people at high risk for lung cancer avoid repeated radiation from regular CT scans.
PessacAges 55–74 - NCT06822530Recruiting
Increasing colon cancer screening after abnormal stool test
This trial tests a multilevel support program to help patients who had an abnormal FIT (fecal immunochemical test) result get a follow-up colonoscopy. The goal is to increase colorectal cancer screening completion.
Seattle, WashingtonAges 45–75 - NCT06817161RecruitingPhase 3
Nerve stimulation for quality of life during ovarian cancer treatment
This trial tests if a gentle nerve stimulation device on the ear can improve quality of life for people with ovarian cancer who are starting their first chemotherapy. It may help manage symptoms like fatigue or feeling sick.
CaenAges 18 years+ - NCT06816394RecruitingPhase 2
Tarlatamab for advanced rare cancers outside the lung
This trial tests a new drug called tarlatamab for people with advanced small cell or neuroendocrine cancers that started outside the lung (like in the stomach, bladder, or head and neck) and have grown after initial chemotherapy. It aims to see if this treatment can shrink or control the cancer.
Taipei, Please SelectAges 18 years+ - NCT06815432RecruitingPhase 1
GPC-3 CAR T cells for recurrent GPC-3 positive glioblastoma
This trial tests whether a special type of immune cell (called CAR T cells) can fight a brain tumor called glioblastoma that has come back. The cells are made to target a protein on the tumor cells, and the study will see if this treatment is safe and helpful.
Houston, TexasAges 21–70 - NCT06816966Enrolling by invitationPhase 2
Chemo-immunotherapy with split radiation for extensive-stage lung cancer
This trial tests a combination of chemotherapy, immunotherapy, and a special type of radiation given in split sessions for people with extensive-stage small cell lung cancer. The goal is to see if this approach can help control the cancer better.
Fuzhou, FujianAges 18 years+ - NCT06815133Recruiting
Study of zilucoplan in French patients with myasthenia gravis
This trial is for people in France with myasthenia gravis who are already taking zilucoplan. It tracks how well and how safely the medicine works over 3 months in everyday practice.
Nice, Alpes MaritimesAges 18 years+ - NCT06820385Recruiting
Wearable AI device for daily radiation therapy guidance
This trial tests a wearable device that uses artificial intelligence to help guide radiation therapy for pelvic cancers. The device may help make daily treatments more accurate, which could improve outcomes and reduce side effects.
Milwaukee, WisconsinAges 18 years+ - NCT06821048RecruitingPhase 1
CAR-T cells targeting CEA for advanced solid tumors
This trial tests a new treatment called CAR-T cells that are designed to attack cancer cells positive for CEA protein. It's for people with advanced solid tumors like colorectal or lung cancer who have run out of standard options.
Hangzhou, ZhejiangAges 18 years+
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,320 recruiting oncology studies from the U.S. registry right now, out of 31,393 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.